Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 31

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 31
---
collectively, “ Patents'');

3. all copyrights in both published works and unpublished works of the Company and each Subsidiary (collectively, “ Copyrights”);

4. all rights in mask works of the Company and each Subsidiary (collectively, “ Rights in Mask Works''); and

5. all know-how, trade secrets, confidential information, customer lists, software, technical information, data, process technology, plans, drawings, and blue prints (collectively, “ Trade Secrets''); owned, used, or licensed by the Company and each Subsidiary as licensee or licensor.

(ii) . There
are no outstanding and, to Company’s knowledge, no threatened disputes or disagreements with respect to any agreements relating
to any Intellectual Property Rights to which the Company and each Subsidiary is a party or by which the Company is bound.

(iii) . The Intellectual Property Rights are all those necessary for the operation of the Company’s and Subsidiaries’
businesses as currently conducted or as represented to the Purchaser to be conducted. Each of the Company and each Subsidiary is the owner
of all right, title, and interest in and to each of their respective Intellectual Property Rights, free and clear of all Liens, and adverse
claims, and has the right to use all of the Intellectual Property Rights. To the Company’s knowledge, no employee of the Company
or any Subsidiary has entered into any contract that restricts or limits in any way the scope or type of work in which the employee may
be engaged or requires the employee to transfer, assign, or disclose information concerning his work to anyone other than the Company
or a Subsidiary.

(iv) . The Company
and each Subsidiary is the owner of all right, title and interest in and to each of the Patents, free and clear of all Liens and adverse
claims. All of the issued Patents are currently in compliance with formal legal requirements (including payment of filing, examination,
and maintenance fees and proofs of working or use), are valid and enforceable, and are not subject to any maintenance fees or taxes or
actions falling due within ninety days after each Closing Date. No Patent has been or is now involved in any interference, reissue, re-examination,
or opposition proceeding. Except as disclosed and described in the SEC Reports, to the Company’s knowledge: (1) there is no potentially
interfering patent or